New India vs ICICI Lombard vs HDFC ERGO — Which Indemnity Policy Should a Doctor Buy?

1. Why these three, and what a comparison can honestly be built from

These are the three names Indian doctors actually shortlist: the public-sector incumbent that has written this line since before liberalisation, the private insurer with the easiest buying journey, and the one genuinely new doctors-specific product to launch in years. What follows compares them on the only evidence that exists.

That qualification is not modesty. There is no claim-settlement ratio for professional indemnity in India. The phrase does not appear in the IRDAI Annual Report, the statistics Handbook, the GI Council Yearbook or the Ombudsman's annual report ^[6,7,8,9], and IRDAI's insurer-wise tables collapse liability into an "Other Segments" bucket shared with crop, credit, engineering and aviation ^[7,6]. So a comparison of these three can be built from filed wordings, from what happens in court, and from complaint counts — and from nothing else. Anyone offering you a settlement-ratio league table for doctors' indemnity is making it up.

2. New India Assurance: the cheapest claim, the hardest document to obtain

New India's advantage is structural and it shows up at exactly the moment you need it. There is no compulsory excess in the wording ^[1,2] — a deliberate inheritance from the 1991 Market Agreement, which prescribed no deductible for doctors and whose DNA all four public-sector wordings still carry ^[2,1,12,13]. Compare that with United India's 0.50% of the limit ^[20], or with ICICI charging its excess against your legal bill ^[5].

Its second advantage is a single phrase most doctors never read. New India undertakes to meet defence costs "whether liability ultimately attaches to the policy or not" ^[1] — the most insured-friendly defence wording of any Indian doctors' policy. In a line where insurers contested 22 of the 25 litigated claims we catalogued ^[11], a clause that funds your lawyer before the coverage argument is settled is worth more than a larger headline limit. New India also publishes the full ratio menu, 1:1 through 1:4 ^[10], letting a doctor buy annual capacity for more than one claim.

The catch is that you cannot easily read any of this. New India does not publish the wording on its own website; the copy we read came through an intermediary ^[1,10]. And it appears in 13 of the 25 judgments in our sweep, more than any other insurer ^[11] — which reflects the size and age of its book rather than a verdict on how it pays, but is worth knowing before you assume a public-sector insurer will not fight you.

3. ICICI Lombard: easy to buy, expensive where it counts

ICICI is where most doctors under forty end up, because it can be bought online in an afternoon and doctors report paying around ₹9,000 a year for ₹1 crore of cover ^[21], and as little as ₹4,000 for the same limit through a different channel ^[22]. The policy also indemnifies each insured person separately, so a practice with named assistants gets cross-liability protection.

Two clauses should change how you price it against New India. The excess applies to defence costs, not only to damages ^[5] — so in every claim, including the ones you win, the retention comes off your legal spend first. And arbitration is a condition precedent to bringing suit against the insurer ^[5], which means a coverage dispute cannot go straight to court. Set against a 12-month sue-or-abandon deadline running from any disclaimer ^{[1,12,13,5,14,15,3]}, that procedural gate deserves more attention than it gets.

The wording itself has not been refreshed in a long time: it still speaks in service-tax-era language ^[5], years after GST replaced it. ICICI also recorded the highest number of general-insurance ombudsman complaints in FY2023-24 ^[9] and leads the liability segment on premium ^[23]. Both figures are all-lines and unnormalised — dominated by motor and health retail — and neither is evidence about doctors' indemnity. We include them because they are the only insurer-level published numbers that exist, and because leaving them out would be the kind of selective quotation this publication exists to correct.

4. HDFC ERGO Mediserve: the only policy you can fully read, and the one that expires hardest

Mediserve is the strongest argument in the Indian market that transparency and quality track together. It is the only doctors' indemnity product whose complete document set — wording, prospectus and customer information sheet — is published ^[3,4]. Set that against the alternatives we catalogued: Oriental's wording is recoverable only through the Wayback Machine ^[13], United India's prospectus opens by describing cover for "the accidental breakage of plate glass" ^[16], and Future Generali publishes nothing at all ^[24].

The drafting is contemporary in a way the 1991-descended wordings are not, with exclusions written for opioid and vaping liability, clinical trials, IVF, wrongful-life claims and anaesthesia not administered by a registered anaesthesiologist ^[3]. Some of those will not apply to you; the point is that someone has read the policy this decade. It also allows terms of up to three years, which removes two renewal dates from your calendar.

Then there is the clause that decides whether you should buy it. Mediserve accepts no claim reported after the policy expires — a zero-day post-expiry reporting window ^[3], where New India, ICICI, the other public-sector insurers, IFFCO and IndusInd all give 90 days ^{[1,12,13,5,14,15]}. Since late notification is the single most litigated reason doctors' claims are refused in India ^[11], and one surgeon lost everything for telling his insurer nine years late ^[25], a zero-day bar converts an administrative slip into a total loss of cover. Cosmetic work is also excluded flat, with none of the burns and trauma carve-backs the public-sector wordings allow ^{[1,12,5,14,15,20,13,3]}.

5. What the public record shows about all three